EQUIPPING PROGRESS

The lab equipment market is expected to boom as investments in life sciences R&D increase to deal with existing and emerging health threats

- LAKSHMIPRIYA NAIR

As pharma companies invest in building the labs of the future, the pharma lab equipment market is expected to boom in the coming decade.

The pandemic has underscored the importance of innovation, investment, and access. It has opened new avenues for the pharma laboratory equipment market from areas higher up in the value chain such as drug discovery, development, and API manufacturing

Amit Chopra Managing Director, India and South Asia, Thermo Fisher Scientific

India is one of the geographies for Agilent where we see great potential and we will continue to focus on expanding our local footprint. One of the focus areas for Agilent is to expand its capabilities and offer a complete biopharma workflow solutions portfolio

Samir Vyas Country Manager, Agilent India

Lab equipment related to cell/microbial cultures, biosafety, sample preparation, sample processing, storage are expected to grow in research, pilot or small-scale production while demand for large volume shakers, fermenters, bioreactors, single use culture vessels, large volume or continuous centrifuges are expected to stay high

Dr D Muruganand Head of Operational Marketing - India, Middle East & Africa, Eppendorf India

With Indian pharma expected to grow at a very impressive CAGR over the next few years, we are very well positioned to serve our customers. Our solutions span across the entire pharma value chain from disease discovery to quality control and manufacturing

Shripad Joshi President - India and South Asia, PerkinElmer